Title: Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501
Title: Molecular evolution of the neuropeptide S receptor.
Journal: PloS one 20120101
Title: Metabolic stability of new anticonvulsants in body fluids and organ homogenates.
Journal: Acta poloniae pharmaceutica 20120101
Title: Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68).
Journal: Journal of medicinal chemistry 20110428
Title: The asthma candidate gene NPSR1 mediates isoform specific downstream signalling.
Journal: BMC pulmonary medicine 20110101
Title: Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).
Journal: PloS one 20110101
Title: Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Journal: Medicinal research reviews 20100901
Title: 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20100715
Title: Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Journal: Peptides 20100501
Title: Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function.
Journal: Peptides 20100101
Title: Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy.
Journal: Infection and drug resistance 20100101
Title: Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors.
Journal: Bioconjugate chemistry 20090318
Title: Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.
Journal: The Journal of pharmacology and experimental therapeutics 20080601
Title: Raltegravir: first in class HIV integrase inhibitor.
Journal: Therapeutics and clinical risk management 20080401
Title: [New derivatives of eremomycin containing (15)n or f atoms for NMR study].
Journal: Bioorganicheskaia khimiia 20080101
Title: Raltegravir in the management of HIV-infected patients.
Journal: Drug design, development and therapy 20080101
Title: From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety.
Journal: Bioorganic & medicinal chemistry letters 20070115
Title: 19F NMR chemical shifts induced by a helical peptide.
Journal: Chembiochem : a European journal of chemical biology 20060701
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells.
Journal: Bioorganic & medicinal chemistry letters 20051015
